Patent · US Active

Peptides and uses thereof for treating cancer

US11926677B2 · kind B2 · utility

0Cited by
0References
17Claims
0Family size

Assignee

Inventor

Key dates

Filing dateOct 30, 2020
Grant dateMar 12, 2024
Priority date
Expiry dateOct 30, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Presented herein are cancer peptide agents and uses thereof for treating cancer and/or inhibiting metastasis. Also presented herein are methods of treating cancer, or inhibiting metastasis of cancer in a subject, comprising administering a therapeutically effective amount of a composition comprising one or more cancer peptide agents to the subject. Also presented herein is a method of treating a cancer in a subject, or inhibiting metastasis of a cancer in a subject that comprises administering a therapeutically effective amount of a composition comprising one or more cancer peptide agents, and administering a chemotherapy or chemotherapeutic agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.